(MedPage Today) — The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
Approval of updated shots also came…
Source link : https://www.medpagetoday.com/infectiousdisease/covid19vaccine/118322
Author :
Publish date : 2025-11-05 18:55:00
Copyright for syndicated content belongs to the linked Source.
